130 related articles for article (PubMed ID: 8688565)
1. A biologically based model for the analysis of premalignant foci of arbitrary shape.
Dewanji A; Luebeck EG; Moolgavkar SH
Math Biosci; 1996 Jul; 135(1):55-68. PubMed ID: 8688565
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
[TBL] [Abstract][Full Text] [Related]
3. Stochastic analysis of intermediate lesions in carcinogenesis experiments.
Luebeck EG; Moolgavkar SH
Risk Anal; 1991 Mar; 11(1):149-57. PubMed ID: 1828119
[TBL] [Abstract][Full Text] [Related]
4. Multistage hepatocarcinogenesis in the rat: insights into risk estimation.
Dragan YP; Pitot HC
Prog Clin Biol Res; 1992; 374():261-79. PubMed ID: 1620707
[No Abstract] [Full Text] [Related]
5. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
6. An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver.
Gindi T; Ghazarian DM; Deitch D; Farber E
Cancer Lett; 1994 Aug; 83(1-2):75-80. PubMed ID: 8062236
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
Sherman CD; Portier CJ
Carcinogenesis; 1995 Oct; 16(10):2499-506. PubMed ID: 7586158
[TBL] [Abstract][Full Text] [Related]
8. Increase of T cells in the liver during hepatocarcinogenesis with N-2-fluorenylacetamide in rats.
Okita K; Ando K; Fukumoto Y; Miyazaki M; Tsubota W; Kodama T; Takemoto T
Gan; 1981 Aug; 72(4):610-4. PubMed ID: 7030859
[TBL] [Abstract][Full Text] [Related]
9. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells.
Geisler I; Kopp-Schneider A
Math Biosci; 2000 Dec; 168(2):167-85. PubMed ID: 11121564
[TBL] [Abstract][Full Text] [Related]
10. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Ohshima M; Ward JM; Brennan LM; Creasia DA
J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
[TBL] [Abstract][Full Text] [Related]
11. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions.
Burkholder I; Kopp-Schneider A
Math Biosci; 2002; 179(2):145-60. PubMed ID: 12208613
[TBL] [Abstract][Full Text] [Related]
12. Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions.
Dewanji A; Moolgavkar SH; Luebeck EG
Math Biosci; 1991 Apr; 104(1):97-109. PubMed ID: 1804458
[TBL] [Abstract][Full Text] [Related]
13. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro.
Moore MA; Kitagawa T
Int Rev Cytol; 1986; 101():125-73. PubMed ID: 3009348
[No Abstract] [Full Text] [Related]
15. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.
Columbano A; Ledda-Columbano GM; Rao PM; Rajalakshmi S; Sarma DS
Am J Pathol; 1984 Sep; 116(3):441-6. PubMed ID: 6476080
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical observation on the proliferative activity of rat liver in early hepatocarcinogenesis].
Xie YJ
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):95-7. PubMed ID: 1914025
[TBL] [Abstract][Full Text] [Related]
17. Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci.
Luebeck EG; Moolgavkar SH; Buchmann A; Schwarz M
Toxicol Appl Pharmacol; 1991 Dec; 111(3):469-84. PubMed ID: 1684071
[TBL] [Abstract][Full Text] [Related]
18. alpha-Fetoprotein levels and hepatic alterations during chemical carcinogenesis in C57BL/6N mice.
Becker FF; Sell S
Cancer Res; 1979 Sep; 39(9):3491-4. PubMed ID: 89897
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic progression in experimental hepatocarcinogenesis.
Scherer E
Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
[TBL] [Abstract][Full Text] [Related]
20. Altered hepatic foci: their role in murine hepatocarcinogenesis.
Pitot HC
Annu Rev Pharmacol Toxicol; 1990; 30():465-500. PubMed ID: 2188576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
